You cannot register for this webinar

As pharmaceutical innovation accelerates in Japan and China, companies are increasingly seeking global licensing and partnership opportunities. However, navigating the complexities of international markets requires a clear understanding of an asset’s clinical and commercial value. In this webinar, we explore a strategic framework for evaluating and positioning R&D-stage assets to support informed investment decisions and successful global deal-making. Through market trends, case studies, and proven methodologies, we’ll demonstrate how a rigorous assessment toolkit can empower pharma companies in Japan and China to unlock global potential.